BAYRY
Price
$6.25
Change
+$0.08 (+1.30%)
Updated
Apr 23 closing price
Capitalization
57.55B
19 days until earnings call
BIIB
Price
$119.62
Change
+$1.45 (+1.23%)
Updated
Apr 24, 02:18 PM (EDT)
Capitalization
31.34B
7 days until earnings call
Ad is loading...

BAYRY vs BIIB

Header iconBAYRY vs BIIB Comparison
Open Charts BAYRY vs BIIBBanner chart's image
Bayer A.G
Price$6.25
Change+$0.08 (+1.30%)
Volume$400.73K
Capitalization57.55B
Biogen
Price$119.62
Change+$1.45 (+1.23%)
Volume$2.51K
Capitalization31.34B
BAYRY vs BIIB Comparison Chart
Loading...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAYRY vs. BIIB commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAYRY is a StrongBuy and BIIB is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (BAYRY: $6.25 vs. BIIB: $118.17)
Brand notoriety: BAYRY: Not notable vs. BIIB: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BAYRY: 60% vs. BIIB: 113%
Market capitalization -- BAYRY: $57.55B vs. BIIB: $31.34B
BAYRY [@Pharmaceuticals: Major] is valued at $57.55B. BIIB’s [@Pharmaceuticals: Major] market capitalization is $31.34B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAYRY’s FA Score shows that 0 FA rating(s) are green whileBIIB’s FA Score has 0 green FA rating(s).

  • BAYRY’s FA Score: 0 green, 5 red.
  • BIIB’s FA Score: 0 green, 5 red.
According to our system of comparison, both BAYRY and BIIB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAYRY’s TA Score shows that 6 TA indicator(s) are bullish while BIIB’s TA Score has 6 bullish TA indicator(s).

  • BAYRY’s TA Score: 6 bullish, 4 bearish.
  • BIIB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BAYRY and BIIB are a good buy in the short-term.

Price Growth

BAYRY (@Pharmaceuticals: Major) experienced а +5.75% price change this week, while BIIB (@Pharmaceuticals: Major) price change was +2.50% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.00%. For the same industry, the average monthly price growth was -3.10%, and the average quarterly price growth was -8.49%.

Reported Earning Dates

BAYRY is expected to report earnings on Aug 06, 2025.

BIIB is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.00% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAYRY($57.5B) has a higher market cap than BIIB($31.3B). BIIB has higher P/E ratio than BAYRY: BIIB (26.95) vs BAYRY (17.04). BAYRY YTD gains are higher at: 28.074 vs. BIIB (-22.724). BAYRY has higher annual earnings (EBITDA): 12.1B vs. BIIB (2.04B). BAYRY has more cash in the bank: 7.98B vs. BIIB (1.05B). BAYRY has higher revenues than BIIB: BAYRY (50.5B) vs BIIB (9.84B).
BAYRYBIIBBAYRY / BIIB
Capitalization57.5B31.3B184%
EBITDA12.1B2.04B594%
Gain YTD28.074-22.724-124%
P/E Ratio17.0426.9563%
Revenue50.5B9.84B513%
Total Cash7.98B1.05B760%
Total DebtN/A7.34B-
FUNDAMENTALS RATINGS
BAYRY vs BIIB: Fundamental Ratings
BAYRY
BIIB
OUTLOOK RATING
1..100
2155
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9167
PRICE GROWTH RATING
1..100
5665
P/E GROWTH RATING
1..100
8396
SEASONALITY SCORE
1..100
5027

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAYRY's Valuation (67) in the null industry is in the same range as BIIB (93) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's Profit vs Risk Rating (100) in the null industry is in the same range as BIIB (100) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BIIB's SMR Rating (67) in the Biotechnology industry is in the same range as BAYRY (91) in the null industry. This means that BIIB’s stock grew similarly to BAYRY’s over the last 12 months.

BAYRY's Price Growth Rating (56) in the null industry is in the same range as BIIB (65) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's P/E Growth Rating (83) in the null industry is in the same range as BIIB (96) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAYRYBIIB
RSI
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 11 days ago
54%
Declines
ODDS (%)
Bearish Trend 18 days ago
70%
Bearish Trend 9 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
52%
Aroon
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGOAX31.65N/A
N/A
Patient Opportunity A
HISCX23.53N/A
N/A
Hartford Small Cap Growth HLS IA
RYTSX43.68N/A
N/A
Rydex Transportation A
FEUCX17.18N/A
N/A
Fidelity Advisor Glbl Capital Apprec C
PWJDX30.04N/A
N/A
PGIM Jennison International Opps R4

BAYRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYRY has been closely correlated with BAYZF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYRY jumps, then BAYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYRY
1D Price
Change %
BAYRY100%
+1.30%
BAYZF - BAYRY
88%
Closely correlated
+0.70%
OPHLY - BAYRY
23%
Poorly correlated
+2.22%
SNY - BAYRY
23%
Poorly correlated
+2.37%
AZN - BAYRY
21%
Poorly correlated
+0.94%
BIIB - BAYRY
20%
Poorly correlated
-0.61%
More

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with OGN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then OGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
-0.61%
OGN - BIIB
48%
Loosely correlated
+2.22%
AMGN - BIIB
47%
Loosely correlated
-0.18%
NVS - BIIB
44%
Loosely correlated
-1.15%
PFE - BIIB
42%
Loosely correlated
-0.62%
AZN - BIIB
36%
Loosely correlated
+0.94%
More